Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENs
Open Access
- 22 March 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (18) , 30395-30409
Abstract
Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENs Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENsKeywords
This publication has 45 references indexed in Scilit:
- Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growthOncotarget, 2015
- Editing genomic DNA in cancer cells with high genetic variance: Benefit or risk?Oncology Reports, 2014
- FLASH assembly of TALENs for high-throughput genome editingNature Biotechnology, 2012
- Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targetingNucleic Acids Research, 2011
- DNMT3AMutations in Acute Myeloid LeukemiaNew England Journal of Medicine, 2010
- Structure and Function of Mammalian DNA MethyltransferasesChemBioChem, 2010
- Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2006
- Glutathione in Cancer Biology and TherapyCritical Reviews in Clinical Laboratory Sciences, 2006
- Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutationsBlood, 2005
- Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2‐mercaptoethanolJournal of Cellular Physiology, 1981